Dr. Lal Path Labs · NSE: LALPATHLAB · BSE: 539524
Q1 FY26 results · Apr–Jun 2025
Dr. Lal Path Labs reported revenue from operations of ₹669.80 crore (up 11.3% from Q1 FY25) and net profit of ₹134.00 crore (up 24.3% from Q1 FY25) for Q1 FY26 (Apr–Jun 2025), on a consolidated basis.
| Item | Q1 FY26 | Q1 FY25 | YoY | Q4 FY25 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 669.80 | 601.90 | +11.3% | 602.60 | +11.2% |
| Other income | 28.10 | 20.60 | +36.4% | 25.80 | +8.9% |
| Total income | 697.90 | 622.50 | +12.1% | 628.40 | +11.1% |
| Profit before tax | 181.10 | 149.90 | +20.8% | 153.40 | +18.1% |
| Net profit for the period | 134.00 | 107.80 | +24.3% | 155.50 | −13.8% |
| Attributable to shareholders of the company | 132.40 | 106.40 | +24.4% | 154.80 | −14.5% |
| EPS, basic (₹) | 15.88 | 12.79 | +24.2% | 18.57 | −14.5% |
| Net margin (%) | 20.0 | 17.9 | 25.8 |
| Item | Q1 FY26 | Q1 FY25 | YoY | Q4 FY25 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 640.70 | 534.50 | +19.9% | 577.20 | +11.0% |
| Other income | 26.30 | 28.80 | −8.7% | 25.20 | +4.4% |
| Total income | 667.00 | 563.30 | +18.4% | 602.40 | +10.7% |
| Profit before tax | 172.40 | 161.00 | +7.1% | 144.90 | +19.0% |
| Net profit for the period | 129.30 | 122.90 | +5.2% | 148.40 | −12.9% |
| EPS, basic (₹) | 15.51 | 14.76 | +5.1% | 17.80 | −12.9% |
| Net margin (%) | 20.2 | 23.0 | 25.7 |
Consolidated
- Filed with BSE
- 31 Jul 2025, 15:55 IST
- Board meeting
- 31 Jul 2025
- Period
- 01 Apr 2025 to 30 Jun 2025
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 31 Jul 2025, 15:55 IST
- Board meeting
- 31 Jul 2025
- Period
- 01 Apr 2025 to 30 Jun 2025
- Review status
- Unaudited
- Source
- XBRL filing on BSE